Nocturnal circulating tumor cells: The ultimate selective filter in cancer progression? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Med Année : 2022

Nocturnal circulating tumor cells: The ultimate selective filter in cancer progression?

Résumé

The survival duration of circulating tumor cells (CTCs) in the vasculature is a critical parameter in the establishment of the metastatic cascade. Diamantopoulou and colleagues demonstrate that the metastatic capacity of CTCs is strongly influenced by circadian rhythms, suggesting a rationale for the time-controlled interrogation and treatment of metastatic cancers.

Domaines

Cancer
Fichier principal
Vignette du fichier
1-s2.0-S2666634022003154-main.pdf (228.63 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Licence

Dates et versions

hal-04235043 , version 1 (22-01-2024)

Licence

Identifiants

Citer

Frédéric Thomas, Antoine M Dujon, Beata Ujvari, Catherine Alix-Panabières. Nocturnal circulating tumor cells: The ultimate selective filter in cancer progression?. Med, 2022, 3 (8), pp.523-525. ⟨10.1016/j.medj.2022.07.005⟩. ⟨hal-04235043⟩
37 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More